NOT-CA-20-023: Notice of a Pre-Application Webinar for RFA-CA-20-032, Radiobiology of High Linear Energy Transfer (High LET) Exposure in Cancer Treatment (R01, Clinical Trial Not Allowed)

Notice of a Pre-Application Webinar for RFA-CA-20-032, Radiobiology of High Linear Energy Transfer (High LET) Exposure in Cancer Treatment (R01, Clinical Trial Not Allowed)

Notice Number: NOT-CA-20-023

Key Dates
Release Date: January 15, 2020

Related Announcements
RFA-CA-20-032

Issued by
National Cancer Institute (NCI)

Purpose

The NCI will hold a pre-application informational WebEx webinar on Thursday, January 30, 2020 at 1:00 PM (ET) for the Funding Opportunity Announcement (FOA) RFA-CA-20-032 entitled "Radiobiology of High Linear Energy Transfer (High LET) Exposure in Cancer Treatment (R01, Clinical Trial Not Allowed)."

NCI staff members involved in this FOA will provide orientation and technical assistance to potential applicants to the above-referenced FOA by explaining the goals and objectives of the FOA and answer questions from webinar attendees.

To join the webinar, click the highlighted link: High LET RFA-CA-20-032 Webinar

Participation in this webinar, although encouraged, is optional, and is not required for the submission of an application in response to RFA-CA-20-032.

Inquiries

Please direct all inquiries to:

Jeffrey Buchsbaum, M.D., Ph.D., A.M.,
National Cancer Institute (NCI)
Telephone: 240-276-5690
Email: jeff.buchsbaum@nih.gov